Tag: report

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS), PepGen (PEPG), Reckitt (RBGLY), or Tempus (TEM) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN), UroGen (URGN), Red Cat (RCAT), or Fortrea (FTRE) To Contact Him Directly To Discuss Their Options

Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A Therapies

KOSICE, Slovakia, July 11, 2025 (GLOBE NEWSWIRE) -- Remittix, a rising decentralized finance (DeFi) project focused on seamless crypto-to-fiat payments, has successfully completed a comprehensive security audit conducted by Certik, a leading blockchain security firm. This achievement marks a key step toward the official launch of Remittix’s PayFi infrastructure—a next-generation payment protocol designed to streamline crypto settlements directly to bank accounts.

LAS VEGAS, July 11, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the full-scale relaunch of its loyalty program. Beginning Friday, July 11, all Planet 13 stores will match any third-party advertised price —a move that firmly positions Planet 13 as the destination offering the Best Product. Best Experience. Best Price.

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee” or the “Corporation”) announces that its wholly owned subsidiary, Dundee Resources Limited, has acquired via a private placement 1,454,553 common shares of Bulgold Inc. (TSXV - ZLTO) (the “Issuer”) at the price of C$0.05 per share for aggregate consideration of C$72,727.65.

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 warrants (approximately ⅓) shall be exercised with cash, and the remainder (approximately 200,000 warrants) to be exercised in a cashless manner.

Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable